MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer

被引:170
|
作者
Wu, Yiying [1 ,2 ]
Song, Yi [3 ]
Xiong, Yao [2 ]
Wang, Xiaodong
Xu, Ke [2 ]
Han, Bin [2 ]
Bai, Yang [2 ]
Li, Li [4 ]
Zhang, Yuanyuan [2 ]
Zhou, Liming [2 ]
机构
[1] Chengdu Med Coll, Sch Pharm, Dept Pharmacol, Chengdu, Sichuan, Peoples R China
[2] West China Sch Preclin & Forens Med, Dept Pharmacol, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, Dept Surg, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Colorectal carcinoma; MiR-21; PTEN; Proliferation; Invasiveness; SIGNALING PATHWAY; PROLIFERATION; APOPTOSIS; METASTASIS; TARGETS; OVEREXPRESSION; INACTIVATION; INHIBITION; EXPRESSION; MIGRATION;
D O I
10.1159/000481648
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: MicroRNA-21 (miR-21) has been demonstrated to play an important role in carcinogenesis; however, its mechanism of action in colorectal cancer (CRC) has not been fully elucidated. The aim of the present study was to explore the oncogenic function of miR-21 and its molecular mechanism in CRC. Methods: A total of 105 paired tumor and tumor-adjacent normal tissue specimens from CRC patients and two CRC cell lines (HCT-116 and SW480) were studied. The protein and mRNA expression levels of PTEN and miR-21 were examined using western blot analysis and real-time reverse transcription-PCR (qRT-PCR). Furthermore, we transfected CRC cells with different combinations of ectopic-expression vector or shRNA expression vector of miR-21 and phosphatase and tensin homolog (PTEN) to modulate the expression levels of miR-21 and PTEN respectively, and then analyzed the phenotypic alterations of CRC cells. Tumorigenesis was also evaluated by xenografting HCT-116 cells into nude mice. Results: In this study, we showed that miR-21 expression was significantly up-regulated in CRC compared to that in normal tissues. Patients with advanced Tumor-Node-Metastasis (TNM) stage, lymph node metastasis, local invasion and higher serum carcinoembryonic antigen (CEA) levels displayed significantly high expression of miR-21. The PTEN protein level in CRC tissues and cells was inversely correlated with miR-21 expression. Furthermore, the transfection of CRC cells with pre-miR-21 could inhibit apoptosis and promote cellular proliferation, invasion, cell cycle progression and growth of xenografts in nude mice, whereas the transfection of miR-21-specific shRNA resulted in the opposite phenomena. In addition, silencing or elevating PTEN protein could partially reverse the effect of miR-21-specific shRNA or pre-miR-21 on apoptosis, cell cycle distribution, and invasion of CRC cells. Moreover, over-expression or knockdown of miR-21 altered the protein expression of PTEN and phosphorylated Akt (p-AKT). Conclusion: miR-21 can modulate the malignant phenotypes such as proliferation, anti-apoptosis, cell cycle progression and invasion of CRC cells by down-regulating PTEN protein expression. The results of study might improve our understanding of the regulatory mechanism of miR-21 and provide useful targets and approaches for the clinical diagnosis and therapy of CRC. (C) 2017 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:945 / 958
页数:14
相关论文
共 50 条
  • [31] Deregulated stromal microrna-21 promotes metastatic progression in colorectal cancer
    Bullock, M. D.
    Pickard, K. M.
    Nielsen, B. S.
    Sayan, A. E.
    Jenei, V.
    Mellone, M.
    Mitter, R.
    Primrose, J. N.
    Thomas, G. J.
    Packham, G. K.
    Mirnezami, A. H.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 45 - 45
  • [32] SAV1, regulated by microRNA-21, suppresses tumor growth in colorectal cancer
    Jiang, Jianwu
    Chang, Wei
    Fu, Yang
    Gao, Yongshun
    Zhao, Chunlin
    Zhang, Xiefu
    Zhang, Shuijun
    BIOCHEMISTRY AND CELL BIOLOGY, 2019, 97 (02) : 91 - 99
  • [33] IDENTIFICATION OF MIR-21 AS TUMOR-SUPPRESSOR AND PROGNOSTIC MARKER IN RENAL CELL CANCER
    Vergho, Daniel
    Kneitz, Susanne
    Eckel, Nils
    Scherer, Charlotte
    Spahn, Martin
    Kneitz, Burkhard
    Riedmiller, Hubertus
    JOURNAL OF UROLOGY, 2010, 183 (04): : E84 - E85
  • [34] MiR-21 promotes pterygium cell proliferation through the PTEN/AKT pathway
    Li, Xia
    Dai, Yiqin
    Xu, Jianjiang
    MOLECULAR VISION, 2018, 24 : 485 - 494
  • [35] Celastrol Inhibits Colorectal Cancer Cell Growth In Vivo by Regulation of miR-21
    Lu, Wen-Zong
    Wang, Kui
    Zhang, Liang
    Pan, Hai-Xian
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (09): : 1833 - 1838
  • [36] The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review
    Far, Bahareh Farasati
    Vakili, Kimia
    Fathi, Mobina
    Yaghoobpoor, Shirin
    Bhia, Mohammed
    Naimi-Jamal, M. Reza
    LIFE SCIENCES, 2023, 316
  • [37] MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer
    Jun Wei
    Lahong Zhang
    Jennifer Li
    Shuguang Zhu
    Minghui Tai
    Clifford W. Mason
    Julia A. Chapman
    Evelyn A. Reynolds
    Carl P Weiner
    Helen H Zhou
    Journal of Ovarian Research, 10
  • [38] Streptomycin, an inhibitor of miR-21 reduces invasion and suppresses tumor growth
    Pore, Subrata Kumar
    Bose, Debojit
    Maiti, Souvik
    Banerjee, Rajkumar
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2015, 52 (3-4): : 227 - 231
  • [39] MicroRNA-205 promotes cell invasion by repressing TCF21 in human ovarian cancer
    Wei, Jun
    Zhang, Lahong
    Li, Jennifer
    Zhu, Shuguang
    Tai, Minghui
    Mason, Clifford W.
    Chapman, Julia A.
    Reynolds, Evelyn A.
    Weiner, Carl P.
    Zhou, Helen H.
    JOURNAL OF OVARIAN RESEARCH, 2017, 10
  • [40] MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival
    Mima, Kosuke
    Nishihara, Reiko
    Yang, Juhong
    Dou, Ruoxu
    Masugi, Yohei
    Shi, Yan
    da Silva, Annacarolina
    Cao, Yin
    Song, Mingyang
    Nowak, Jonathan
    Gu, Mancang
    Li, Wanwan
    Morikawa, Teppei
    Zhang, Xuehong
    Wu, Kana
    Baba, Hideo
    Giovannucci, Edward L.
    Meyerhardt, Jeffrey A.
    Chan, Andrew T.
    Fuchs, Charles S.
    Qian, Zhi Rong
    Ogino, Shuji
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3841 - 3848